Lord Kamall

A timely diagnosis is vital to ensuring that a person with dementia can access the advice, information, care, and support that can help them to live well and remain independent for as long as possible. We remain committed to recovering the dementia diagnosis rate to the national ambition of 66.7%.

The Neighbourhood Health Service will bring together teams of professionals closer to people’s homes to work together to provide comprehensive care in the community. Whilst no specific assessment has been made regarding dementia diagnosis rates, we expect neighbourhood teams and services to be designed in a way that reflects the specific needs of local populations. While we will be clear on the outcomes we expect, we will give significant licence to tailor the approach to local need. While the focus on personalised, coordinated care will be consistent, that will mean the services will look different in rural communities, coastal towns, and/or deprived inner cities.

Our health system has struggled to support those with complex needs, including those with dementia. Under the 10-Year Health Plan, those living with dementia will benefit from improved care planning and better services.

The Department is committed to funding health and care research via the National Institute for Health and Care Research (NIHR) across England, to ensure that the research we support is inclusive and representative of the populations we serve.

In 2024, the NIHR made equity, diversity, and inclusion a condition of funding for all domestic research awards. This means applicants must demonstrate how their research will contribute towards the NIHR’s mission to reduce health and care inequalities, with a focus on participant inclusion from diverse populations of the United Kingdom.

NIHR research infrastructure has national coverage across the whole of England. Our infrastructure schemes aim to build research capacity and capability across the country, across all geographies and settings. In line with prior commitments, the Department has increased funding for NIHR research infrastructure schemes delivering cancer research outside the Greater South East, including Biomedical Research Centres, Clinical Research Facilities, and HealthTech Research Centres.

Through the NIHR Research Delivery Network (RDN), the NIHR provides funding to 100% of National Health Service trusts in England to deliver research, operating across 12 regions throughout the country. From 2026/27, the RDN will adopt a new national funding model for NHS support costs and research delivery. This will be a consistent, nationally agreed funding distribution model across all regions of England and will reduce regional variation in health research delivery investment. This aims to reduce inequity in research delivery across all therapy and geography areas, including in underserved areas and settings.

The NIHR also provides an online service called Be Part of Research which promotes participation in health and social care research by allowing users to search for relevant studies and register their interest. This makes it easier for people to find and take part in health and care research that is relevant to them.

NHS England wrote to the National Health Service providers’ chief financial officers and research and development directors on 30 May 2025, requiring them to ensure all commercial trial activities are invoiced in a timely manner. A copy of this correspondence is attached.

NHS England is currently holding a series of round tables to explore the challenges facing some NHS providers in maintaining good financial management for research, and this includes invoicing. The outcome of these roundtables will be the revision and strengthening of NHS England’s Research Finance Guidance, which was first published in 2024.

The Government publishes United Kingdom-wide data on clinical research delivery performance through the Department’s UK Clinical Research Delivery (UKCRD) Key Performance Indicator Report. This monthly report brings together data from the National Institute for Health and Care Research (NIHR) and the Medicines and Healthcare products Regulatory Agency to monitor system-wide progress in the delivery of globally competitive clinical research across the UK. Alongside this reporting, the Department also publishes National Health Service trust level data on the study set-up performance of sites in England.

The Health and Care Act 2022 sets legal duties for integrated care boards (ICBs) in relation to research, and these duties include requirements to include research in ICB joint forward plans and reports. The Department and NHS England are currently developing plans for the future structure and functions of ICBs and regions and this includes consideration of where governance for research will sit. In May, NHS England wrote a letter to NHS providers requiring board-level reporting of research activity and income, with scrutiny of the UKCRD programme’s site-level performance metrics for study set-up. A copy of this correspondence is attached. NHS England will publish revised guidance on financial management for research later in 2025.

Regional pilots such as the Targeted Lung Health Check can be used to build an evidence base and inform decisions regarding screening. However, the Department is guided on screening policy by the UK National Screening Committee (UK NSC). This is an independent scientific advisory committee and makes its recommendations based on internationally recognised criteria and a rigorous evidence review and consultation process.

Regional screening initiatives would only be rolled out nationally when they followed a UK NSC recommendation based on scientific evidence that showed the programme would do more good than harm at reasonable cost.

The Department and NHS England are taking a number of steps to support the National Health Service to deliver cost-effective, lifesaving prehabilitation and rehabilitation services.

Local planning for prehabilitation and rehabilitation services is a matter for NHS trusts and Cancer Alliances to take forward in their local areas. NHS England has highlighted the positive impact of efficient prehabilitation and rehabilitation on cancer outcomes and the potential to lead to cost savings. The ‘PRosPer’ Cancer Prehabilitation and Rehabilitation learning programme, launched in partnership between NHS England and Macmillan Cancer support, aims to support allied health professionals and the wider healthcare workforce in developing their skills in providing prehabilitation and rehabilitation, including in areas such as exercise, nutrition, and wellbeing support.

The Government and NHS England recognise that for most people living with long term conditions, including people living with cancer, physical activity is safe and can support recovery after treatment and promote quality of life. The NHS is committed to ensuring that all cancer patients in England have access to personalised care, including a needs assessment, a care plan, and health and wellbeing information and support.

Our 10-Year Health Plan for England has set out a series of national actions to address the major risk factors associated with cancer. The National Cancer Plan, due to be published later this year, will build on the shift from sickness to prevention set out in the 10-Year Health Plan. The plan will seek to reduce cancer risk factors, including smoking, and will include further detail about how we will improve outcomes for cancer patients.

The 10-Year Health Plan also committed to ensuring all hospitals integrate ‘opt-out’ smoking cessation interventions into routine care. Within their 2025/26 allocations, integrated care boards have access to funding in order to support the rollout of tobacco dependency treatment services in hospital settings, including acute and mental health inpatient settings and maternity services. Future funding decisions, including any decision to expand tobacco dependency treatment services to additional settings beyond routine care, are subject to the Spending Review process.

The Government is committed to raising the healthiest generation of children ever. This includes all children and young people with special educational needs and disabilities, including non-hearing children. Auditory verbal therapy is one of a range of approaches that can be used with deaf babies and children.

NHS England and the Department for Education are co-funding £10 million over two years in nine Early Language Support for Every Child pathfinder sites to improve early identification, universal and targeted support for speech, language and communication needs in early years and primary schools, with quicker referrals to specialist services when needed.

Delivering services that will raise the healthiest generation of children ever begins with its people. We will publish a 10 Year Workforce Plan to create a workforce ready to deliver a transformed service. The 10 Year Workforce Plan will ensure the National Health Service has the right people in the right places, with the right skills to deliver the best care for patients, when they need it.

There are no current plans to allow patients to directly nominate a distance selling pharmacy (DSP) from within the NHS App. A discovery exercise completed in January 2025 explored this option and concluded that within the current landscape of DSPs there are several challenges that could impact user experience and timely access to medicines. This has been communicated to relevant DSP stakeholders.

The NHS App supports seamless pharmacy services by allowing patients to order repeat prescriptions, nominate their preferred pharmacy, and manage their medication. A new prescription tracker feature means that nearly 1,500 pharmacies are now offering the new prescription tracking service through the NHS App, which provides updates on when prescriptions are ready to be collected. Work has also commenced on an ‘in App’ notification which will enhance this feature further.

On 7 April 2025 the Prime Minister announced that the Government and the Wellcome Trust will invest up to £600 million to create a new Health Data Research Service, co-designed through engagement with the public and patients, data users, and stakeholder organisations.

Providing access to data for direct care purposes is not one of the Health Data Research Service’s planned capabilities. The Health Data Research Service will deliver a single point of access to health data for research from multiple sources, National Health Service and non-NHS. This service will bring new treatments and cures to patients by safely enabling the use of patient data to super-charge research, attracting investment and making the United Kingdom one of the best places in the world to conduct ground-breaking medical research.

The Health Data Research Service will be delivered across the UK to provide a single, integrated system for approved researchers across all sectors to access health, social care, and public health data safely. The service will streamline and simplify current processes, ensuring the safety and security of the data, allowing researchers to spend less time talking to different NHS bodies around the country and more time unlocking new insights that will transform our understanding of health.

NHS England has written to National Health Service trusts, integrated care boards, and primary care networks to reiterate their responsibilities to their staff as employers, including providing pastoral support where required. Importantly, NHS England has also written directly to staff most affected by the recommendations, in the Response to Recommendations from the Independent Review of Physician Associates and Anaesthesia Associates (the Leng Review), available on the NHS.UK website, setting out where they can find support if required.

Implementing the recommendations will require organisations to work together and take action. Some actions will be implemented immediately, whilst others will require wider input, with benefits being fully realised over time. The Department and NHS England will work to ensure that both patient and staff needs are met throughout this process. We will also work collaboratively with other key partners to set out a clear implementation plan for making the required changes, in advance of publishing a fuller response.

According to the latest published data from May 2025, there are 28,250 full time equivalent (FTE) fully qualified general practitioners (GPs). The corresponding headcount figure is 38,868.

Compared to May 2024, there has been a net increase of 601 FTE fully qualified GPs in May 2025. The net increase in headcount over the same period is 1,293.

Data on the number of vacancies is not held centrally.

According to the latest published data from May 2025, there are 28,250 full time equivalent (FTE) fully qualified general practitioners (GPs). The corresponding headcount figure is 38,868.

Compared to May 2024, there has been a net increase of 601 FTE fully qualified GPs in May 2025. The net increase in headcount over the same period is 1,293.

Data on the number of vacancies is not held centrally.

According to the latest published data from May 2025, there are 28,250 full time equivalent (FTE) fully qualified general practitioners (GPs). The corresponding headcount figure is 38,868.

Compared to May 2024, there has been a net increase of 601 FTE fully qualified GPs in May 2025. The net increase in headcount over the same period is 1,293.

Data on the number of vacancies is not held centrally.

Fracture Liaison Services are commissioned by integrated care boards, which are well-placed to make decisions according to local need.

Our 10-Year Health Plan committed to rolling out Fracture Liaison Services across every part of the country by 2030.

Health and care professionals and other staff responsible for caring for patients within health and social care organisations will be able to access their single patient records under strict role-based access controls. Other Government organisations and public bodies will not have corporate access to the single patient record. The record will be protected by the highest standards of security, with a robust audit trail for patients of who has accessed their record.

The geography of neighbourhoods should be determined locally by integrated care boards in partnership with their strategic partners, particularly local authorities. The Government aims to establish a Neighbourhood Health Centre in every community as we shift from hospital to community. Nationwide coverage will take time, but we will start in areas with the greatest need, for instance where healthy life expectancy is lowest, including coastal towns and communities with higher deprivation levels. Wherever possible, we will maximise value for money by repurposing poorly used, existing National Health Service and public sector estates. The Department is also currently writing a business case on Public Private Partnerships for Neighbourhood Health Centres for review as part of the Autumn Budget.

The Neighbourhood Health Service will embody our new preventative principle that care should happen as locally as it can, digitally by default, in a patient’s home if possible, in a Neighbourhood Health Centre when needed, and only in a hospital if necessary. The Neighbourhood Health Service will mean millions of patients are treated and cared for closer to home by new teams of professionals. We have launched the National Neighbourhood Health Implementation Programme to support systems across the country to test new ways of working, share learning, and scale what works. This programme will inform future strategy and policy development, and outcome metrics will be rigorously monitored.

To support neighbourhood health, we will introduce two new contracts, with roll-out beginning next year, one of which will create neighbourhood providers that deliver enhanced services for groups with similar needs over a footprint of approximately 50,000 people. In many areas, existing groups of general practices will be well placed to take on these contracts.

The Professional Standards Authority for Health and Social Care (PSA) operates an accredited voluntary register scheme for professions not subject to statutory regulation.

The Government values the scheme and the PSA quality mark demonstrates a register’s commitment to high standards of care and provides assurance around professional standards and ethical behaviours.

The scheme covers voluntary registers across a range of professions, including a number relating to counselling and psychotherapy.

The NHS.UK website sets out that professionals must be on one of the PSA’s accredited registers in order to work as a counsellor in the National Health Service.

The Professional Standards Authority for Health and Social Care (PSA) operates an accredited voluntary register scheme for professions not subject to statutory regulation.

The Government values the scheme and the PSA quality mark demonstrates a register’s commitment to high standards of care and provides assurance around professional standards and ethical behaviours.

The scheme covers voluntary registers across a range of professions, including a number relating to counselling and psychotherapy.

The NHS.UK website sets out that professionals must be on one of the PSA’s accredited registers in order to work as a counsellor in the National Health Service.

To support the delivery of this ambition, the Department, through NHS England, has put in place new national service specifications, covering both Principal Treatment Centres and the associated Teenage and Young Adult (TYA) Designated Hospital provision, and has established networks to oversee pathways of care, coordinate clinical trial access, and develop local strategies to increase clinical trial recruitment. Alongside this, NHS England has also introduced a metric to monitor trial participation within the TYA Cancer Quality Dashboard.

The Department does not hold data on the overall percentage of children and young people with cancer that are enrolled into clinical trials nationwide but does collect data on general participation through National Institute for Health and Care Research) funded research infrastructure. The Department reports on this data where it is appropriate to do so.

Since it’s relaunch in February 2025, the Children and Young People Cancer Taskforce has been exploring ways to improve outcomes and experiences for children and young people with cancer, including by improving access to research. The National Cancer Plan, due for publication later this year, will set out further details on how we will improve outcomes for all cancer patients, including young people.

The Expert Advisory Group on Allergy (EAGA), which is co-chaired by the Department, currently advises the Department, NHS England and other Government departments on the priority areas for policy change and development related to allergy care and outcomes. The EAGA will continue to support the Department and its partners to ensure that the specific needs of people with allergies are addressed through broader National Health Service reforms.

The 10-Year Health Plan will ensure a better health service for everyone, regardless of condition or geography. Its three big shifts, namely from hospital to community, from analogue to digital, and from sickness to prevention will all help deliver improvements to allergy care. With more tests delivered in the community and better joint working with multidisciplinary teams, including allergy specialists, working in local communities as part of the neighbourhood health service. The greater use of apps and wearable technology will also support people to manage their allergies closer to home.

We are committed ensuring we have the staff we need in the NHS, and we want to hear from partners to make sure we have the right people, in the right places, with the right skills. We will provide more details about what will be included in the 10-Year Workforce Plan in due course.

The Additional Roles Reimbursement Scheme aims to enhance the overall capacity of and capabilities of primary care teams to address a wide range of patient needs and broader healthcare challenges in their localities. Networks may recruit dieticians and nurses with advanced skills and knowledge in a specific area of healthcare or disease management depending upon the needs of their populations.

NHS England does not collect national data on allergy prevalence or services, nor does it issue specific guidance. In conducting health needs assessments to inform their commissioning decisions, integrated care boards will have access to a wide range of data sources, including public health data, hospital statistics, primary care data, and social care metrics.

The Expert Advisory Group on Allergy (EAGA), which is co-chaired by the Department, currently advises the Department, NHS England and other Government departments on the priority areas for policy change and development related to allergy care and outcomes. The EAGA will continue to support the Department and its partners to ensure that the specific needs of people with allergies are addressed through broader National Health Service reforms.

The 10-Year Health Plan will ensure a better health service for everyone, regardless of condition or geography. Its three big shifts, namely from hospital to community, from analogue to digital, and from sickness to prevention will all help deliver improvements to allergy care. With more tests delivered in the community and better joint working with multidisciplinary teams, including allergy specialists, working in local communities as part of the neighbourhood health service. The greater use of apps and wearable technology will also support people to manage their allergies closer to home.

We are committed ensuring we have the staff we need in the NHS, and we want to hear from partners to make sure we have the right people, in the right places, with the right skills. We will provide more details about what will be included in the 10-Year Workforce Plan in due course.

The Additional Roles Reimbursement Scheme aims to enhance the overall capacity of and capabilities of primary care teams to address a wide range of patient needs and broader healthcare challenges in their localities. Networks may recruit dieticians and nurses with advanced skills and knowledge in a specific area of healthcare or disease management depending upon the needs of their populations.

NHS England does not collect national data on allergy prevalence or services, nor does it issue specific guidance. In conducting health needs assessments to inform their commissioning decisions, integrated care boards will have access to a wide range of data sources, including public health data, hospital statistics, primary care data, and social care metrics.

The Expert Advisory Group on Allergy (EAGA), which is co-chaired by the Department, currently advises the Department, NHS England and other Government departments on the priority areas for policy change and development related to allergy care and outcomes. The EAGA will continue to support the Department and its partners to ensure that the specific needs of people with allergies are addressed through broader National Health Service reforms.

The 10-Year Health Plan will ensure a better health service for everyone, regardless of condition or geography. Its three big shifts, namely from hospital to community, from analogue to digital, and from sickness to prevention will all help deliver improvements to allergy care. With more tests delivered in the community and better joint working with multidisciplinary teams, including allergy specialists, working in local communities as part of the neighbourhood health service. The greater use of apps and wearable technology will also support people to manage their allergies closer to home.

We are committed ensuring we have the staff we need in the NHS, and we want to hear from partners to make sure we have the right people, in the right places, with the right skills. We will provide more details about what will be included in the 10-Year Workforce Plan in due course.

The Additional Roles Reimbursement Scheme aims to enhance the overall capacity of and capabilities of primary care teams to address a wide range of patient needs and broader healthcare challenges in their localities. Networks may recruit dieticians and nurses with advanced skills and knowledge in a specific area of healthcare or disease management depending upon the needs of their populations.

NHS England does not collect national data on allergy prevalence or services, nor does it issue specific guidance. In conducting health needs assessments to inform their commissioning decisions, integrated care boards will have access to a wide range of data sources, including public health data, hospital statistics, primary care data, and social care metrics.

Government responsibility for delivering dementia research is shared between the Department of Health and Social Care, with research delivered via the National Institute for Health and Care Research (NIHR), and the Department for Science, Innovation and Technology, with research delivered via UK Research and Innovation.

The Department of Health and Social Care is committed to ensuring that all patients, including those with dementia, have access to cutting-edge clinical trials and innovative, lifesaving treatments.

As an example, the Department, via the NIHR, is investing nearly £50 million into the Dementia Trials Network, a coordinated network of trial sites across the United Kingdom, which will offer people with dementia the opportunity to take part in early phase clinical trials irrespective of where they live. This is complemented by the £20 million Dementia Trials Accelerator, designed to position the UK as the destination of choice for late phase clinical trials in dementia and neurodegenerative diseases.

The NIHR also funds research infrastructure which supports patients and the public to participate in high-quality research, including research on dementia. For example, the aim of the University College London Hospitals’ Biomedical Research Centre’s dementia theme is to develop novel treatments through precision medicine. The theme’s focus on young onset and familial dementias provides key insights into the factors that can cause or speed up neurodegeneration, allowing a window for treatments to be administered, before functional decline occurs.

In partnership with Alzheimer’s Society, Alzheimer’s Research UK, and Alzheimer Scotland, the NIHR also delivers Join Dementia Research, an online platform which enables the involvement of people with and without a dementia diagnosis, as well as carers, to take part in a range of important research, including studies evaluating potential treatments for dementia.

The Government’s Dame Barbara Windsor Dementia Goals programme, which is expected to have nearly £150 million of Government funding allocated to it, or aligned with it, aims to speed up the development of new treatments for dementia and neurodegenerative conditions by accelerating innovations in biomarkers, clinical trials, and implementation.

We recognise the importance of a timely diagnosis and remain committed to increasing diagnosis rates and ensuring that people can access any licensed and National Institute for Health and Care Excellence-recommended treatment and/or support they need. The Government is investing in dementia research across all areas, from causes, diagnosis and prevention, to treatment, care, and support, including for carers.

The NHS Health Check, a core component of England’s cardiovascular disease (CVD) prevention programme, aims to prevent some cases of dementia in eligible people by making them aware that many of the risk factors for CVD are the same as those for dementia, and what is good for the heart is good for the brain. While there are no plans to incorporate early cognitive screening in the NHS Health Check, for those aged 65 to 74 years old, the programme signposts individuals to memory services if appropriate.

Our health system has struggled to support those with complex needs, including those with dementia. Under the 10-Year Plan, those living with dementia will benefit from improved care planning and better services. We will deliver the first ever Modern Service Framework for Frailty and Dementia to deliver rapid and significant improvements in quality of care and productivity. This will be informed by phase one of the independent commission into adult social care, expected in 2026.

We recognise the importance of a timely diagnosis and remain committed to increasing diagnosis rates and ensuring that people can access any licensed and National Institute for Health and Care Excellence recommended treatment and/or support they need.

Our health system has struggled to support those with complex needs, including those with dementia. Under the 10-Year Plan, those living with dementia will benefit from improved care planning and better services. We will deliver the first ever Modern Service Framework for Frailty and Dementia to deliver rapid and significant improvements in quality of care and productivity.

Support for self-care is an essential service that all pharmacies must provide, and can include the provision of advice, information, and where appropriate, the sale of over-the counter-medicines to patients, carers, and the general public to support their self-care for minor ailments. This gives patients easy access to advice from highly trained and skilled healthcare professionals in the community and relieves pressure in other areas of the National Health Service.

Under Pharmacy First, NHS 111, general practices, and accident and emergency departments can refer patients to see a pharmacist for advice on a minor illness, which may include the sale of over-the-counter medicines. They can also refer patients to one of the Pharmacy First seven clinical pathways, as part of which pharmacies can supply prescription-only medicines to patients. Patients can also walk into a pharmacy for treatment as part of the seven clinical pathways.

The 10-Year Health Plan describes a shared vision for the health and care system in 2035, drawing directly from the extensive engagement that has been undertaken with the public, patients, and staff. The plan includes how care models and pathways will need to change or evolve to better meet their needs, and the cultural and behavioural changes we want to see.

There are no current plans to allow patients to directly nominate a distance selling pharmacy (DSP) from within the NHS App. Patients can continue to nominate a DSP through existing routes, which currently provide a more seamless patient experience.

The Department does not hold this information as the 2025 medical specialty recruitment process is still ongoing.

NHS England has a Data Sharing Agreement, project code DARS-NIC-381078-Y9C5K, with a consortium of academic organisations in the United Kingdom for the purpose of the Health Data Research UK-led, British Heart Foundation Data Science Centre’s CVD-COVID-UK programme. This agreement was put in place by NHS Digital prior to its merger with NHS England in 2023.

The agreement was subject to reviews by NHS Digital’s Independent Group Advising on Release of Data on 25 June 2020, 23 July 2020, 15 October 2020, 3 December 2020, 25 February 2021, 29 July 2021, 5 May 2022, and 24 November 2022. It was also subject to advice from the Professional Advisory Group on 24 June 2020 and 28 July 2021.

As part of the agreed process, all projects undertaken under this agreement required approval by the CVD-COVID-UK Approvals and Oversight Board. NHS Digital/NHS England had a representative on that board and through this decision-making forum, engaged in discussions with Health Data Research UK about projects that used NHS England’s data for pandemic planning and research.

For a project to proceed, approval was required from the NHS Digital/NHS England representative and from the board as a whole. Under the terms of the agreement, the CVD-COVID-UK oversight committee is required to maintain a list of projects undertaken under the agreement and must provide a quarterly report to NHS Digital/NHS England.

Subsequently, concerns have been raised by the Royal College of General Practitioners and the British Medical Association in relation to the Foresight project which was undertaken under the above agreement. NHS England has confirmed to the Royal College of General Practitioners and the British Medical Association that NHS England’s Data Protection Officer is undertaking assurance, and NHS England has met operationally with others, including Health Data Research UK, in relation to this work.

The General Practice Extraction Service Data for Pandemic Planning and Research is not being used for direct care decisions.

NHS England has a Data Sharing Agreement, project identification code DARS-NIC-381078-Y9C5K, with a consortium of academic organisations in the United Kingdom for the purpose of the Health Data Research UK-led, British Heart Foundation Data Science Centre’s CVD-COVID-UK programme.

This agreement was put in place by NHS Digital prior to its merger with NHS England in 2023, and prior to the establishment of NHS England’s Advisory Group for Data (AGD). The AGD was informed of a Senior Information Risk Owner decision to approve an amendment to the agreement on 22 February 2024.

The agreement was subject to reviews by NHS Digital’s Independent Group Advising on the Release of Data (IGARD) on 25 June 2020, 23 July 2020, 15 October 2020, 3 December 2020, 25 February 2021, 29 July 2021, 29 July 2021, 5 May 2022, and 24 November 2022. It was also subject to advice from the Professional Advisory Group on 24 June 2020 and 28 July 2021.

The agreement allowed the data controllers under that agreement to approve access to National Health Service data for individual projects, subject to approval per project by the CVD-COVID-UK oversight committee, which included a representative of NHS Digital/NHS England. Individual projects were not reviewed by IGARD or the AGD.

Under the terms of the agreement, the CVD-COVID-UK oversight committee is required to maintain a list of projects undertaken under the agreement and provide a quarterly report to NHS Digital/NHS England. The following table lists the projects and their current status from the latest report provided in April 2025:

The status of project CCU078 has been updated to reflect that NHS England paused the project on 29 May. Further detail on the projects is published on the British Heart Foundation Data Science Centre’s website.

The single patient record will give staff in any provider access to the information they need to provide care, and would end the need for patients to have to repeat their medical history when interacting with the National Health Service.

We are currently in the early stages of considering the scope, and this includes what information patients will be able to see about when and where their record is accessed. Our engagement with the public identified the importance of there being an audit trail of access.

We will mandate its use by the NHS and social care, so that everyone has the opportunity to have a single patient record.

The single patient record will give staff in any provider access to the information they need to provide care, and would end the need for patients to have to repeat their medical history when interacting with the National Health Service.

We are currently in the early stages of considering the scope, and this includes what information patients will be able to see about when and where their record is accessed. Our engagement with the public identified the importance of there being an audit trail of access.

We will mandate its use by the NHS and social care, so that everyone has the opportunity to have a single patient record.

The Department does not hold data on medical specialty training places by integrated care board but is able to present data by National Health Service training region. Data is only available for the combined obstetrics and gynaecology specialist training pathway, as opposed to specifically gynaecology specialist training. The following table shows the number of obstetrics and gynaecology specialist training posts available in the 2023 and 2024 entry rounds by region:

Source: NHS England, available on the NHS.UK website, in an online only format.

The table presents the number of posts offered at both specialist training stages one and three. The latter meaning medical professionals will already have undertaken at least two years of relevant training or equivalent before entry to this later stage of the specialty training programme.

We are committed to training the staff we need to ensure patients are cared for by the right professional, when and where they need it. This is central to the vision in our 10 Year Plan. 
 
We will ensure that the number of medical specialty training places meets the demands of the NHS in the future. NHS England will work with stakeholders to ensure that any growth is sustainable and focused in the service areas where need is greatest.

The Department does not hold data on medical specialty training places by integrated care board, but is able to present data by National Health Service training region. The following table shows the number of trauma and orthopaedics specialist training posts available in the 2023 and 2024 entry rounds by region:

Source: NHS England, available on the NHS.UK website, in an online only format.

The table presents the number of posts offered at specialist training stage three, meaning medical professionals will already have undertaken at least two years of relevant core training or equivalent before entry to this specialty training programme.

We are committed to training the staff we need to ensure patients are cared for by the right professional, when and where they need it. This is central to the vision in our 10 Year Plan. 
 
We will ensure that the number of medical specialty training places meets the demands of the NHS in the future. NHS England will work with stakeholders to ensure that any growth is sustainable and focused in the service areas where need is greatest.